Information:
Fel:
Nyckelord
Plasmodium属感染症 ×
- Malaria Vaccines (57)
- Clinical Trial, Phase II (54)
- Clinical Trial (52)
- Plasmodium falciparum (41)
- Vaccines (37)
- Clinical Trial, Phase III (21)
- Follow-Up Studies (11)
- Adverse event (8)
- Concomitant Medication (6)
- Trial screening (6)
- Laboratories (6)
- Safety (5)
- Eligibility Determination (5)
- Patient Participation (5)
- Vaccination (4)
- End of Study (4)
- Physical Examination (3)
- On-Study Form (3)
- Demography (3)
- Hematocrit (3)
- Random Allocation (2)
- Reference Values (2)
- Seizures (2)
- Serology (2)
- Malaria, Falciparum (2)
- Body Weight (2)
- Symptom Assessment (2)
- Patient Reported Outcome (PRO) (2)
- Aftercare (2)
- Drug Administration Routes (2)
- Informed Consent (2)
- Medical History Taking (2)
- Antibodies (2)
- Research Personnel (1)
- Travel (1)
- Hepatitis B Vaccines (1)
- Blood (1)
- Consent Forms (1)
- Mosquito Nets (1)
- Insecticide-Treated Bednets (1)
- Lost to Follow-Up (1)
- Patient Safety (1)
- Clinical Laboratory Services (1)
- Pre-Study Form (1)
- Patient information (1)
- Geographic Locations (1)
Innehållsförteckning
Valda datamodeller
Du måste vara inloggad för att välja flera datamodeller, ladda ner dem eller analysera dem.
79 Sökresultat.
Item-grupp: pht006804
pht006805.v1.p1
1 Item-grupp 8 Dataelementpht006802.v1.p1
1 Item-grupp 2 Dataelementpht006803.v1.p1
1 Item-grupp 3 Dataelement Item-grupper: Administrative Data, SAE, Seriousness, Demography Data, Investigational Product, Possible causes of SAE, Relevant Medical Conditions, Other relevant risk factors, Relevant Concomitant Medication, Details of investigational product, Details of relevant assessments, Narrative remarks, SAE additional / Follow-up information, Investigator's signature
Item-grupper: Administrative, Serious Adverse Events, Document section, Document Section SAE, Document Section Demography Data, Document section SAE recurrence, Document Section SAE Causations, Document Section Medical Conditions, Document Section Risk Factors, Document Section Pharmaceutical Preparations, Document Section Investigational Drug Details, Document Section Evaluation Procedures, Document Section Narrative Remarks, Investigator's Signature, Document Section SAE follow-up information, Investigator's Signature
Item-grupper: Administrative, Clinical Chemistry, Haematology, Serology, CMI Sample
Item-grupper: Administrative, Solicited Adverse Events Local Symptoms Present, Solicited Adverse Events Local Symptoms Specification, Solicited Adverse Events Local Symptoms Duration, Solicited Adverse Events General Symptoms Present, Solicited Adverse Events General Symptoms Specification, Solicited Adverse Events General Symptoms Duration, Unsolicited Adverse Events
Item-grupper: Administrative, Local Symptoms (at Injection Site), Local Symptoms (at Injection Site), Other Local Symptoms, Pharmaceutical preparation, General Symptoms, General Symptoms, General Symptoms, Other General Symptoms, Administrative
Item-grupper: Administrative, Laboratory Reference Ranges, Laboratory Reference Ranges
Item-grupper: Administrative, Concomitant Vaccination, Concomitant Vaccination
Item-grupper: Administrative, Active Case Detection Malaria, Treated Bed Net, Indoor Residual Spray
Item-grupper: Administrative, Passive Case Detection Malaria
Efficacy of P. Falciparum Vaccine Against Malaria in Children NCT00380393 - Absences from Study Area
Item-grupper: Administrative, Absences from Clinical Trial Area Duration, Absences from Clinical Trial Area Duration
Item-grupper: Administrative, Generalized convulsive seizures